The Efficacy and Safety of Guselkumab Induction Therapy in Patients With Moderately to Severely Active Ulcerative Colitis: Phase 2b QUASAR Study Results Through Week 12.
Unknown authors
Topics & Concepts
Ulcerative colitisMedicineQuasarInternal medicineGastroenterologyDiseasePhysicsAstrophysicsGalaxyInflammatory Bowel DiseaseHelicobacter pylori-related gastroenterology studiesMicroscopic Colitis